The post US SEC’s crypto ETF rules review delays 21Shares Spot SUI approval appeared on BitcoinEthereumNews.com. The US Securities and Exchange Commission (SEC) has opted to delay its verdict on the 21Shares Spot SUI ETF. Such delays often indicate that the regulator wants to examine a proposal in greater detail before issuing a ruling. On behalf of the asset manager, Nasdaq had lodged a Form 19b-4 with the SEC on May 23, requesting permission to list and trade the fund’s shares. Since then, the regulator has extended the review period on July 22 and formally launched proceedings to determine if the SUI ETF meets the requirements for approval. It even invited the public to share written feedback, including opinions, data, and concerns on the proposal. The US SEC has to decide on the 21Shares SUI ETF by December 21 Nasdaq had filed for the SUI ETF shortly after a major attack on Cetus that drained over $223 million and disrupted the Sui ecosystem. Nonetheless, the exchange’s team acted quickly, locking down $160 million in stolen funds and offering a $6 million reward for the recovery of the rest. The company noted at that time, “With the funds secured, Cetus has officially entered the next phase of the recovery process. Our team is fully mobilized and working around the clock to execute the roadmap we shared earlier — from contract upgrades and liquidity restoration to preparations for relaunch.” After that, the Sui network confirmed the hack was due to a flaw in Cetus’s math library, not its own infrastructure or programming language. It also unveiled a $10 million fund to bolster ecosystem security. The SEC’s decision to delay the approval of the SUI spot ETF, according to some analysts, could dampen short-term confidence, as it delays the institutional participation and market expansion opportunities tied to the ETF.  Nevertheless, the commission must make a final decision on the… The post US SEC’s crypto ETF rules review delays 21Shares Spot SUI approval appeared on BitcoinEthereumNews.com. The US Securities and Exchange Commission (SEC) has opted to delay its verdict on the 21Shares Spot SUI ETF. Such delays often indicate that the regulator wants to examine a proposal in greater detail before issuing a ruling. On behalf of the asset manager, Nasdaq had lodged a Form 19b-4 with the SEC on May 23, requesting permission to list and trade the fund’s shares. Since then, the regulator has extended the review period on July 22 and formally launched proceedings to determine if the SUI ETF meets the requirements for approval. It even invited the public to share written feedback, including opinions, data, and concerns on the proposal. The US SEC has to decide on the 21Shares SUI ETF by December 21 Nasdaq had filed for the SUI ETF shortly after a major attack on Cetus that drained over $223 million and disrupted the Sui ecosystem. Nonetheless, the exchange’s team acted quickly, locking down $160 million in stolen funds and offering a $6 million reward for the recovery of the rest. The company noted at that time, “With the funds secured, Cetus has officially entered the next phase of the recovery process. Our team is fully mobilized and working around the clock to execute the roadmap we shared earlier — from contract upgrades and liquidity restoration to preparations for relaunch.” After that, the Sui network confirmed the hack was due to a flaw in Cetus’s math library, not its own infrastructure or programming language. It also unveiled a $10 million fund to bolster ecosystem security. The SEC’s decision to delay the approval of the SUI spot ETF, according to some analysts, could dampen short-term confidence, as it delays the institutional participation and market expansion opportunities tied to the ETF.  Nevertheless, the commission must make a final decision on the…

US SEC’s crypto ETF rules review delays 21Shares Spot SUI approval

For feedback or concerns regarding this content, please contact us at [email protected]

The US Securities and Exchange Commission (SEC) has opted to delay its verdict on the 21Shares Spot SUI ETF. Such delays often indicate that the regulator wants to examine a proposal in greater detail before issuing a ruling.

On behalf of the asset manager, Nasdaq had lodged a Form 19b-4 with the SEC on May 23, requesting permission to list and trade the fund’s shares.

Since then, the regulator has extended the review period on July 22 and formally launched proceedings to determine if the SUI ETF meets the requirements for approval. It even invited the public to share written feedback, including opinions, data, and concerns on the proposal.

The US SEC has to decide on the 21Shares SUI ETF by December 21

Nasdaq had filed for the SUI ETF shortly after a major attack on Cetus that drained over $223 million and disrupted the Sui ecosystem. Nonetheless, the exchange’s team acted quickly, locking down $160 million in stolen funds and offering a $6 million reward for the recovery of the rest.

The company noted at that time, “With the funds secured, Cetus has officially entered the next phase of the recovery process. Our team is fully mobilized and working around the clock to execute the roadmap we shared earlier — from contract upgrades and liquidity restoration to preparations for relaunch.”

After that, the Sui network confirmed the hack was due to a flaw in Cetus’s math library, not its own infrastructure or programming language. It also unveiled a $10 million fund to bolster ecosystem security.

The SEC’s decision to delay the approval of the SUI spot ETF, according to some analysts, could dampen short-term confidence, as it delays the institutional participation and market expansion opportunities tied to the ETF. 

Nevertheless, the commission must make a final decision on the 21Shares SUI ETF by December 21, but could greenlight it as early as October, potentially in tandem with other altcoin ETFs.

So far, 21Shares and Canary Capital are the only asset managers to seek approval for a Sui ETF, with CBOE filing Canary’s application last month.

Analysts believe SEC delays are part of its strategy

The SEC, in August, also postponed its verdict on Grayscale’s request to incorporate staking into its ETH fund, as well as on 21Shares’ spot Ethereum staking proposal and Grayscale’s spot Dogecoin ETF filing. Additionally, it chose to extend its review period for Bitcoin and Ethereum ETFs proposed by Truth Social, the social platform owned by Trump Media & Technology Group.

Nonetheless, Nate Geraci of NovaDius Wealth previously shared that he believes an SEC decision on ETF staking could be imminent, after the commission stated that specific liquid staking arrangements do not involve securities.

Analysts Eric Balchunas and James Seyffart of Bloomberg also suggested that the SEC’s recent delays are part of a deliberate strategy to develop a unified approval framework for digital-asset ETFs. Seyffart explained that this framework would set out common listing standards, specifying which assets are eligible for inclusion and the approval criteria, eliminating the need for a separate order for each filing.

Meanwhile, the three major exchanges, Nasdaq, NYSE, and CBOE BZX, remain in discussions over standardized rules for spot crypto ETF listings with the SEC. As part of this effort, they filed amendments recently to strike “excluded commodities” from the definition of “commodity” in their listing standards.

KEY Difference Wire helps crypto brands break through and dominate headlines fast

Source: https://www.cryptopolitan.com/us-sec-review-delays-21shares-sui-etf/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11
US, UK, Canada Launch Operation Atlantic to Tackle Crypto Scams

US, UK, Canada Launch Operation Atlantic to Tackle Crypto Scams

Law enforcement agencies from the United States, United Kingdom, and Canada have launched Operation Atlantic, a joint effort to combat rising crypto scams and protect
Share
Coinlaw2026/03/17 22:11